Humana/$HUM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Humana
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Ticker
$HUM
Sector
Primary listing
NYSE
Employees
65,680
Headquarters
Website
Humana Metrics
BasicAdvanced
$33B
21.20
$13.04
0.45
$3.54
1.28%
Price and volume
Market cap
$33B
Beta
0.45
52-week high
$320.56
52-week low
$206.87
Average daily volume
1.6M
Dividend rate
$3.54
Financial strength
Current ratio
1.952
Quick ratio
1.522
Long term debt to equity
68.795
Total debt to equity
70.424
Dividend payout ratio (TTM)
27.22%
Interest coverage (TTM)
5.79%
Profitability
EBITDA (TTM)
4,015
Gross margin (TTM)
15.03%
Net profit margin (TTM)
1.28%
Operating margin (TTM)
3.06%
Effective tax rate (TTM)
24.88%
Revenue per employee (TTM)
$1,870,000
Management effectiveness
Return on assets (TTM)
4.69%
Return on equity (TTM)
9.03%
Valuation
Price to earnings (TTM)
21.198
Price to revenue (TTM)
0.271
Price to book
1.82
Price to tangible book (TTM)
4.6
Price to free cash flow (TTM)
13.659
Free cash flow yield (TTM)
7.32%
Free cash flow per share (TTM)
20.238
Dividend yield (TTM)
1.28%
Forward dividend yield
1.28%
Growth
Revenue change (TTM)
9.88%
Earnings per share change (TTM)
-6.80%
3-year revenue growth (CAGR)
10.80%
10-year revenue growth (CAGR)
8.97%
3-year earnings per share growth (CAGR)
-18.95%
10-year earnings per share growth (CAGR)
4.43%
3-year dividend per share growth (CAGR)
5.97%
10-year dividend per share growth (CAGR)
12.10%
What the Analysts think about Humana
Analyst ratings (Buy, Hold, Sell) for Humana stock.
Bulls say / Bears say
Humana raised its full-year 2025 adjusted EPS guidance to approximately $17.00 from $16.25, surpassing the analyst consensus of $16.38 and fueling a nearly 6% premarket share gain on July 30, 2025. (Reuters)
Outperformance in the CenterWell primary care unit, evidenced by stronger-than-expected patient growth and service revenue, diversified Humana’s revenue base and underpinned its Q2 earnings beat. (Reuters)
Humana’s public support for legislative efforts to curb controversial Medicare Advantage billing practices signals proactive regulatory cooperation that may reduce future compliance costs and reputational risk. (Reuters)
Despite improved retention, Humana still anticipates declines in Medicare Advantage membership in 2025, which could constrain premium revenue growth. (Reuters)
A Texas federal judge dismissed Humana’s challenge to its reduced CMS star ratings, risking lower Quality Bonus Payments and potential adverse impacts on 2026 government reimbursements. (Reuters)
Humana’s medical cost ratio remained elevated at 89.7% in Q2 2025, up from 88.9% a year ago, reflecting persistent utilization pressures that could erode margin improvements. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 30 Aug 2025.
Humana Financial Performance
Revenues and expenses
Humana Earnings Performance
Company profitability
Humana News
AllArticlesVideos
Humana Announces New Agreements to Expand Specialized Care Programs for Patients Living with Musculoskeletal Conditions
Business Wire3 weeks ago
Humana Earns 2025 Great Place to Work Certification™ and PEOPLE Companies That Care® Recognition
Business Wire3 weeks ago
Humana Board Declares Payment of Quarterly Dividend to Stockholders
Business Wire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Sept26
Humana
DividendEx-dividend
Oct31
Humana
DividendPayment
$0.885Per share
FAQs
What’s the current market cap for Humana stock?
Humana (HUM) has a market cap of $33B as of September 14, 2025.
What is the P/E ratio for Humana stock?
The price to earnings (P/E) ratio for Humana (HUM) stock is 21.2 as of September 14, 2025.
Does Humana stock pay dividends?
Yes, the Humana (HUM) stock pays dividends to shareholders. As of September 14, 2025, the dividend rate is $3.54 and the yield is 1.28%. Humana has a payout ratio of 27.22% on a trailing twelve-month basis.
When is the next Humana dividend payment date?
The next Humana (HUM) dividend payment is scheduled for October 31, 2025.
What is the beta indicator for Humana?
Humana (HUM) has a beta rating of 0.45. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.